Medtronic Invests $700M in Heart Tech

Medtronic has invested over $700 million in heart technology and robotics, including a stake in Pi-Cardia, a company focused on heart valve technology. This investment is part of Medtronic's efforts to expand its presence in the cardiovascular market.

Medtronic's cardiovascular business has seen significant growth, with sales jumping 19.5% to $3.93 billion. The company has also reported Q1 2027 revenue of $9.76 billion and adjusted EPS of $1.45.

Medtronic has a market cap of $117.8 billion and a global workforce serving patients across more than 150 countries. The company's shares rose 1.5% on September 1 after it raised its fiscal 2027 organic revenue growth outlook to 7.25% - 7.75%.

## Why it matters Medtronic's investment in Pi-Cardia and its increased outlook for fiscal 2027 reflect the company's commitment to innovation and growth in the healthcare technology sector. With a global presence and a wide range of medical solutions, Medtronic is well-positioned to address complex health challenges and improve patient outcomes.

The company's focus on heart valve technology is particularly significant, given the growing demand for innovative treatments and solutions in this area. Medtronic's investment in Pi-Cardia is expected to drive growth and expansion in this market, and its increased outlook for fiscal 2027 suggests that the company is confident in its ability to deliver strong results.

Medtronic's shares have been trading below their 50-day and 200-day moving averages since mid-February, but have moved above their 50-day moving average since July. The company's stock has risen 27.1% over the past three months, outperforming the broader Dow Jones Industrials Average's 3.7% gain over the same time frame.

## What happens next Medtronic's investment in Pi-Cardia and its increased outlook for fiscal 2027 are expected to drive growth and expansion in the healthcare technology sector. The company's focus on innovation and its commitment to improving patient outcomes are likely to continue to drive its success in the future. As the demand for innovative treatments and solutions continues to grow, Medtronic is well-positioned to meet this demand and deliver strong results.